Tag: <span>RET gene fusion</span>

Home / RET gene fusion
Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions
Post

Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions

by University of Texas M. D. Anderson Cancer Center Credit: Unsplash/CC0 Public Domain The highly selective RET inhibitor pralsetinib was well-tolerated and demonstrated robust, durable responses in patients with RET fusion-positive cancers regardless of tumor type, according to results from the international Phase I/II ARROW trial led by researchers at The University of Texas MD...